• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.

作者信息

Oberfield S E, Levine L S, Carey R M, Greig F, Ulick S, New M I

出版信息

J Clin Endocrinol Metab. 1983 Feb;56(2):332-9. doi: 10.1210/jcem-56-2-332.

DOI:10.1210/jcem-56-2-332
PMID:6296185
Abstract

A syndrome of low renin hypertension in childhood with apparent mineralocorticoid excess associated with a defect in the peripheral metabolism of cortisol has been described previously in 2 patients. In these patients, decreased secretion rates of glucocorticoids, mineralocorticoids, and sex steroids have been demonstrated. In a 10(10/12)-yr-old girl with this disorder, continuous iv administration of hydrocortisone in doses of 5, 10, 15, and 20 mg/day resulted in an increase in blood pressure and a decrease in serum potassium concentration. The addition of spironolactone during the continued administration of 20 mg/day hydrocortisone did not result in a decrease in blood pressure. Withdrawal of hydrocortisone and continued administration of spironolactone alone resulted in a decrease in blood pressure, a rise in serum potassium concentration, and a fall in serum sodium concentrations. These studies suggest that an abnormality in cortisol action or metabolism causing cortisol to behave as a potent mineralocorticoid may account for this syndrome of apparent mineralocorticoid excess.

摘要

相似文献

1
Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
J Clin Endocrinol Metab. 1983 Feb;56(2):332-9. doi: 10.1210/jcem-56-2-332.
2
Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.
J Clin Endocrinol Metab. 1977 May;44(5):924-33. doi: 10.1210/jcem-44-5-924.
3
New findings in apparent mineralocorticoid excess.表观盐皮质激素过多的新发现。
Clin Endocrinol (Oxf). 1987 Jul;27(1):49-62. doi: 10.1111/j.1365-2265.1987.tb00838.x.
4
Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.儿童中导致高血压和低钾血症的表观盐皮质激素过多症。
Clin Exp Hypertens A. 1986;8(4-5):751-72. doi: 10.3109/10641968609046592.
5
Apparent mineralocorticoid excess syndrome: report of one family with three affected children.表观盐皮质激素过多综合征:一个有三名患病儿童的家庭报告。
J Pediatr Endocrinol Metab. 2012;25(11-12):1083-8. doi: 10.1515/jpem-2012-0113.
6
A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol.
J Clin Endocrinol Metab. 1979 Nov;49(5):757-64. doi: 10.1210/jcem-49-5-757.
7
Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans.
J Hypertens Suppl. 1996 Dec;14(5):S37-41.
8
Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess.
J Clin Endocrinol Metab. 1990 Jan;70(1):200-6. doi: 10.1210/jcem-70-1-200.
9
[Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].[11β-羟类固醇脱氢酶缺乏所致表观盐皮质激素过多综合征:对一个智利家族进行19年随访的临床与遗传学研究]
Rev Med Chil. 2000 Jan;128(1):17-26.
10
[A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].[一例由2型11β-羟类固醇脱氢酶缺乏引起的表观盐皮质激素过多症]
Arch Mal Coeur Vaiss. 1997 Aug;90(8):1111-5.

引用本文的文献

1
11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.11β-羟甾体脱氢酶:一个不断壮大的多功能家族。
Mol Cell Endocrinol. 2021 Apr 15;526:111210. doi: 10.1016/j.mce.2021.111210. Epub 2021 Feb 17.
2
Clinical and Molecular Perspectives of Monogenic Hypertension.单基因高血压的临床与分子视角
Curr Hypertens Rev. 2020;16(2):91-107. doi: 10.2174/1573402115666190409115330.
3
A case of Liddle syndrome: correspondence.
Indian J Pediatr. 2014 Nov;81(11):1278. doi: 10.1007/s12098-014-1450-3. Epub 2014 May 15.
4
Distinction between Liddle syndrome and apparent mineralocorticoid excess.
Pediatr Nephrol. 2004 Jan;19(1):118-9. doi: 10.1007/s00467-003-1311-1. Epub 2003 Nov 19.
5
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.儿童类固醇疾病:先天性肾上腺增生症和表观盐皮质激素过多症。
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12790-7. doi: 10.1073/pnas.96.22.12790.
6
Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.表观盐皮质激素过多“II型变异型”高血压的分子基础。
Am J Hum Genet. 1998 Aug;63(2):370-9. doi: 10.1086/301955.
7
Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.高剂量皮质醇引起人体钠潴留并非由盐皮质激素受体介导的证据。
J Endocrinol Invest. 1995 Jul-Aug;18(7):586-91. doi: 10.1007/BF03349774.
8
Apparent mineralocorticoid excess syndromes.表观盐皮质激素过多综合征
J Endocrinol Invest. 1995 Jul-Aug;18(7):518-32. doi: 10.1007/BF03349763.
9
Fatal, low renin hypertension associated with a disturbance of cortisol metabolism.与皮质醇代谢紊乱相关的致命性低肾素性高血压。
Arch Dis Child. 1983 Dec;58(12):1018-20. doi: 10.1136/adc.58.12.1018.
10
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.表观盐皮质激素过多综合征。皮质醇 - 可的松穿梭缺陷。
J Clin Invest. 1988 Jul;82(1):340-9. doi: 10.1172/JCI113592.